Bruce Willis Diagnosed With Frontotemporal Dementia, Family Says

Topline Actor Bruce Willis has been diagnosed with frontotemporal dementia, a disease that causes functional decline, his family announced in a statement Thursday, saying his “condition has progressed...

Retirement may be bad for your brain. Is working longer the solution?

When we retire from our jobs we may be giving up more than staff meetings, desk lunches and a paycheck. The social interaction and mental challenges found through work can be good for our mental healt...

ALS, Dementia And Strokes Worsened By Climate Change, Researchers Find

Topline Rising global temperatures and the spread of airborne pollutants could worsen the symptoms of neurological diseases including dementia, strokes, Parkinson’s disease and ALS, researchers warned...

An Alzheimer’s Drug’s Big Surprise: What It Means

Until this past week, there seemed to be no answers to the Alzheimer’s puzzle. The leading theory of the disease, that it was caused by a buildup of beta amyloid plaque in the brain, had been disprove...

Dementia May Lead To Greater Risk Of Covid Death Than Previously Thought, Study Suggests

Topline Conditions like Alzheimer’s and dementia may put patients at an even greater risk of death from Covid-19 than heart disease and other ailments thought to be the most dangerous, according to a ...

Cancer And Dementia Patients Face Higher Risk Of Breakthrough Covid, Studies Find

Topline Vaccinated people with cancer or dementia face a higher risk of contracting breakthrough Covid-19 infections, according to a pair of new studies, leading researchers to argue high-risk patient...

Samuel L. Jackson On Why Bringing ‘Ptolemy Grey’ To The Screen Was Personal

Samuel L. Jackson attends the Premiere of Apple TV+’s ‘The Last Days of Ptolemy Grey’ at Regency … [+] Bruin Theatre in Los Angeles, California. FilmMagic The Last Days of Ptol...

Biogen Stock Has Fallen 50%. Why It’s Time to Buy.

Text size Biogen’s Alzheimer’s disease treatment was once expected to be a megablockbuster. Dominick Reuter/AFP via Getty Images Shares of the biotech firm Biogen are down 50% since June 1...

Biogen’s stock tumbles after the U.S. proposes restricting access to its Alzheimer’s disease drug

Biogen Inc.’s BIIB, -8.92% stock sank 9.3% in premarket trading on Wednesday, the day after regulators proposed limiting access to the class of Alzheimer’s disease drugs that includes the company’s th...

Biogen’s Alzheimer’s Drug Aduhelm Has Another Shot at Success

Illustration by Elias Stein Text size Biogen ’s Alzheimer’s disease therapy, Aduhelm, has been a disappointment for the company since its Food and Drug Administration approval last spring, with early ...

Nearly 153 Million Adults Will Have Dementia Worldwide By 2050, Study Predicts

Topline The number of adults worldwide with dementia could rise from about 57.4 million in 2019 to 152.8 million by 2050, driven by factors like midlife obesity, smoking and social isolation, accordin...